文献速递皮肤肿瘤

德国非黑色素瘤皮肤癌发病率、死亡率及趋势

Incidence, Mortality, and Trends of Nonmelanoma Skin Cancer in Germany.
PubMed 文献 · J Invest Dermatol · 2017-05-06

该研究基于德国萨尔兰和石勒苏益格-荷尔斯泰因两州癌症登记数据,分析1970至2012年非黑色素瘤皮肤癌发病与死亡趋势。结果显示年龄标化和粗发病率均大幅上升,死亡率稳定或下降,预测到2030年发病率将翻倍。

要点

  • 1970至2012年萨尔兰州年龄标化发病率上升10倍,粗发病率上升22倍。
  • 1999至2012年石勒苏益格-荷尔斯泰因粗发病率翻倍,2012年达250例/10万人年。
  • 预测2030年年龄标化发病率男性230例、女性180-200例。

核心结论

  • 德国非黑色素瘤皮肤癌发病率持续长期上升,无平台期趋势,预计到2030年发病率将翻倍。

研究设计与样本

  • 基于萨尔兰和石勒苏益格-荷尔斯泰因联邦州癌症登记数据的趋势分析,使用Joinpoint回归模型估计年度百分比变化及95%置信区间,并通过年龄-时期-队列模型和线性外推预测至2030年。

主要发现

  • 萨尔兰州1970至2012年非黑色素瘤皮肤癌年龄标化发病率上升10倍,粗发病率上升22倍。
  • 石勒苏益格-荷尔斯泰因1999至2012年粗发病率翻倍,2012年达250例/10万人年,年龄标化发病率上升1.5倍。
  • 同期非黑色素瘤皮肤癌死亡率保持稳定或下降。
  • 预测2030年年龄标化发病率为男性230例、女性180-200例;粗发病率为男性450-500例、女性380-430例。

临床怎么用

  • 提示皮肤科医生应关注非黑色素瘤皮肤癌发病率持续上升的趋势,加强早期筛查和预防宣教。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

Increasing incidence rates (IRs) of nonmelanoma skin cancer (NMSC) in white populations have been described worldwide. Cancer registry data from the Saarland and Schleswig-Holstein federal states were used to analyze incidence and mortality trends in Germany. Age-standardized rates were compared with crude rates to assess disease burden. Joinpoint regression models were used to estimate annual percentage changes and 95% confidence intervals, allowing us to assess temporal trends between 1970 and 2012. Incidence predictions until 2030 were based on age-period-cohort models and linear extrapolation techniques. In the Saarland federal state, between 1970 and 2012, NMSC age-standardized and crude IRs increased 10- to 22-fold, respectively. In Schleswig-Holstein, between 1999 and 2012 crude IRs doubled, reaching 250 cases/100,000 persons per year in 2012, with age-standardized IRs increasing 1.5-fold. During this period, NMSC mortality remained stable or decreased. For 2030, the predicted age-standardized IRs are as follows: males, 230 cases; females, 180-200 cases. The predicted crude IRs for the same year are males, 450-500 cases; females, 380-430 cases. There is a continuous long-term increase of NMSC incidence with no tendency for leveling off. By 2030, the current NMSC IR in Germany is expected to double.

来源:J Invest Dermatol,查看原文。版权归原作者所有。

引用

  1. Leiter U, Keim U, Eigentler T, et al. Incidence, Mortality, and Trends of Nonmelanoma Skin Cancer in Germany. J Invest Dermatol. 2017. PMID: 28487088. doi:10.1016/j.jid.2017.04.020

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。